Hi all,
I know this board has been very busy discussing NTNX horrible quarter, which was great, but I have the feeling that some other stories maybe didn’t get the attention they deserve. I’m talking about the accounting change of Alteryx.
Ethan wrote about it, got 31 recs, but no one replied:
https://discussion.fool.com/ayx-asc-606-and-q4-34146055.aspx?sor…
Darth brought up a good point about lumpiness of Alteryx’ revenues going forward due to the accounting change and it sparked a little discussion over at the NPI:
https://discussion.fool.com/ayx-asc-606-lookback-34150145.aspx?s…
I just want to summarize what I think are the most important points about the change in my opinion:
- This is just an accounting change and will not influence how the company structures their deals and does business. It also doesn’t change how much revenue the company will make in the long term, it just changes the way revenue is spread over the contract duration.
- The company will now account 35%-40% of the total contract value (TCV) at the contract signing. The rest of TCV will be accounted ratably over the duration of the contract. This means that revenue will be recognized much more up-front (i.e. today’s revenue goes up a lot but tomorrow there is not so much recurring revenue left to recognize; but then when the contract gets renewed revenue shoots up again), deferred revenue will be much lower, and calculated billings will not be a helpful metric to follow going forward.
- Because of the new revenue recognition method, revenue will be much lumpier and follow the seasonal patterns of billings. Billings have been very strong in Q4, followed by a big sequential drop in Q1. In Q2 and Q3 sequential growth picks up again.
As I said, long-term this doesn’t change anything, in my view, but I was contemplating a lot about the short-term impacts of this change. Are there any?
When an analyst asked in the call what would be the guidance in Q1 if they were reporting under ASC 605, this was the answer:
“Yes. Thanks, Michael. So, for the first question, I mean, it’s really hard to compare. Both the 605 and the 606 are just different mechanics. And we’re not guiding forward under 605. So, it would be hard for me to draw that correlation other than to say if you just look at our 606 guidance, that should reflect the strength that we’re seeing in the business.”
Not really helping alot… Over on NPI I argued that even though the new accounting standard changes the sequential patterns, it shouldn’t impact the yoy-growth rate really. I still believe that.
But here is what confuses me a bit:
Due to the change to ASC 606, 2018 revenue and GAAP EPS went up to $254 million (from $204 million; +20%) and $0.43 (from $-0.29; +167%). At the same time the shares went down from $79 to $67. That’s down 15%, back about where we where in mid January, even though the valuation on EV/S basis went down considerably. Even taking their low-ball 2019 guidance of $350 million they have a forward EV/S of around 12 now.
So if, as is my opinion, nothing really material changed due to the accounting changes, why was the market selling off shares even though their numbers have gotten so much better (yes, numbers went up artifically but still the valuation compressed quite a bit now)? Am I missing something? Is this simply the market being cautious and unsure? Is there more to it? Is this a buying opportunity?
Would love some input and opinions!
Best,
Niki